These included 11q22.2 silent FA-HNSCC, VU1131-T, the 11q22.2 gained/amplified FA-HNSCCs, VU1604-T, VU974-T and VU1365-T, as well as the non-tumor 11q22.2 silent ARPE-19-hTERT WT and FANCA.KO (Fig. 5e). Here, FANCA is linked to head and neck squamous cell carcinoma.